SEC Form 4 · accession 0001645627-17-000034
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 12, 2017
Accepted (ET)
Apr 17, 2017 · 1:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.053 | A | 20,134,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.05 | A | 20,135,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.0529 | A | 20,136,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.0528 | A | 20,137,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.0582 | A | 20,138,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.0589 | A | 20,139,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.059 | A | 20,140,849 | D | |
| Common Stock | Apr 12, 2017 | P | 1,000 | $0.058 | A | 20,141,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0581 | A | 20,142,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,143,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,144,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0539 | A | 20,145,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,146,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,147,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,148,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.053 | A | 20,149,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0508 | A | 20,150,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0515 | A | 20,151,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0515 | A | 20,152,849 | D | |
| Common Stock | Apr 13, 2017 | P | 2,000 | $0.0515 | A | 20,154,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0497 | A | 20,155,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 20,156,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0515 | A | 20,157,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0515 | A | 20,158,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0578 | A | 20,159,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.058 | A | 20,160,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.055 | A | 20,161,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.055 | A | 20,162,849 | D | |
| Common Stock | Apr 13, 2017 | P | 2,000 | $0.055 | A | 20,164,849 | D | |
| Common Stock | Apr 13, 2017 | P | 1,000 | $0.0559 | A | 20,165,849 | D |
Table II — derivative securities
No Table II lines on this filing.